DONNA COLQUHOUN: Open Payments
NPI 1548457260 · MADISON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,053 in 103 payments from 22 companies in 2025. Trend: 2023 $1,859 · 2024 $2,237 · 2025 $2,053
Food & beverage: $2,053
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $395 |
| PFIZER INC. | 21 | $369 |
| Janssen Biotech, Inc. | 11 | $210 |
| Organon LLC | 8 | $163 |
| UCB, Inc. | 7 | $159 |
| Novartis Pharmaceuticals Corporation | 4 | $110 |
| Galderma Laboratories, L.P. | 5 | $109 |
| GENZYME CORPORATION | 4 | $90 |
| LEO Pharma Inc. | 4 | $86 |
| Lilly USA, LLC | 2 | $54 |
Products named: CIBINQO, RINVOQ, TREMFYA, Bimzelx, SKYRIZI, DUPIXENT, NEMLUVIO, Rhapsido.
Industry payments across CT — which companies pay providers there.
